Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Barbara Peter
Observed names:
B Peter,
B. Peter
Institutions:
Ludwig Boltzmann Institute for Hematology and Oncology,
Medical University of Vienna
Observed institutions:
University of Vienna,
TU Wien,
University of Veterinary Medicine Vienna,
Ludwig Boltzmann Institute for Cancer Research,
Ludwig Boltzmann Institute for Hematology and Oncology,
Medical University of Vienna
show all 6
ORCID:
0000-0001-5701-5412
Observed ORCID:
0000-0001-5701-5412
OpenAlex ID:
A5043531746
Transcriptional plasticity promotes primary and acquired resistance to BET inhibition
2015
·
Philipp Rathert
, Mareike Roth
, et al.
·
Nature
·
546
The coffee components kahweol and cafestol induce γ-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat
2001
·
Wolfgang W. Huber
, Gerlinde Scharf
, et al.
·
Archives of Toxicology
·
105
Biogeography and phenotypic variation in Trichoderma sect. Longibrachiatum and associated Hypocrea species
1997
·
Doris Turner
, Werner Kovacs
, et al.
·
Mycological Research
·
103
Polo-like Kinase 1 (Plk1) as a Novel Drug Target in Chronic Myeloid Leukemia: Overriding Imatinib Resistance with the Plk1 Inhibitor BI 2536
2010
·
Karoline V. Gleixner
, Veronika Ferenc
, et al.
·
Cancer Research
·
94
Midostaurin: a magic bullet that blocks mast cell expansion and activation
2017
·
P. Valent
, C. Akin
, et al.
·
Annals of Oncology
·
88
PDF
Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML
2015
·
Irina Sadovnik
, Andrea Hoelbl-Kovacic
, et al.
·
Clinical Cancer Research
·
77
Identification of proapoptotic Bim as a tumor suppressor in neoplastic mast cells: role of KIT D816V and effects of various targeted drugs
2009
·
Karl J. Aichberger
, Karoline V. Gleixner
, et al.
·
Blood
·
69
Expression and dimerization of the rat activin subunits betaC and betaE: evidence for the ormation of novel activin dimers
2002
·
S Vejda
, M Cranfield
, et al.
·
Journal of Molecular Endocrinology
·
68
PDF
Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth
2015
·
B Peter
, G E Winter
, et al.
·
Leukemia
·
67
Expression of activins C and E induces apoptosis in human and rat hepatoma cells
2003
·
S. Vejda
, Natascha Erlach
, et al.
·
Carcinogenesis
·
65
Proposed Diagnostic Criteria and Classification of Canine Mast Cell Neoplasms: A Consensus Proposal
2021
·
Michael Willmann
, Vilma Yuzbasiyan-Gurkan
, et al.
·
Frontiers in Veterinary Science
·
61
H1-receptor antagonists terfenadine and loratadine inhibit spontaneous growth of neoplastic mast cells
2010
·
Emir Hadzijusufovic
, Barbara Peter
, et al.
·
Experimental Hematology
·
58
In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V
2010
·
Alexandra Böhm
, Karoline Sonneck
, et al.
·
Experimental Hematology
·
55
Synergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816V
2013
·
K. V. Gleixner
, B. Peter
, et al.
·
Haematologica
·
51
PDF
Identification of Ponatinib as a potent inhibitor of growth, migration, and activation of neoplastic eosinophils carrying FIP1L1-PDGFRA
2014
·
Irina Sadovnik
, Els Lierman
, et al.
·
Experimental Hematology
·
46
PDF
Comparative oncology: The paradigmatic example of canine and human mast cell neoplasms
2018
·
Michael Willmann
, Emir Hadzijusufovic
, et al.
·
Veterinary and Comparative Oncology
·
43
PDF
5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS-demethylation and FAS re-expression, and synergism with FAS-ligand
2012
·
Viviane Ghanim
, Harald Herrmann
, et al.
·
Blood
·
41
PDF
The pan-Bcl-2 blocker obatoclax promotes the expression of Puma, Noxa, and Bim mRNA and induces apoptosis in neoplastic mast cells
2013
·
Barbara Peter
, Sabine Cerny-Reiterer
, et al.
·
Journal of Leukocyte Biology
·
40
Follistatin overexpression in rodent liver tumors: A possible mechanism to overcome activin growth control
2002
·
Walter Rossmanith
, Monika Chabicovsky
, et al.
·
Molecular Carcinogenesis
·
40
Plasma from Cancer Patients Featuring a Characteristic Protein Composition Mediates Protection against Apoptosis
2002
·
Susanne Vejda
, Carsten Posovszky
, et al.
·
Molecular & Cellular Proteomics
·
39
PDF
The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis
2018
·
Mathias Schneeweiss
, Barbara Peter
, et al.
·
Haematologica
·
38
Preclinical human models and emerging therapeutics for advanced systemic mastocytosis
2018
·
Michel Arock
, Ghaith Wedeh
, et al.
·
Haematologica
·
34
The Hsp32 Inhibitors SMA-ZnPP and PEG-ZnPP Exert Major Growth-Inhibitory Effects on D34+/CD38+ and CD34+/CD38- AML Progenitor Cells
2012
·
H. Herrmann
, M. Kneidinger
, et al.
·
Current Cancer Drug Targets
·
34
The JAK2 / STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma
2017
·
Alexandra Keller
, Bettina Wingelhofer
, et al.
·
Veterinary and Comparative Oncology
·
31
BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph+ chronic myeloid leukemia
2022
·
Barbara Peter
, Gregor Eisenwort
, et al.
·
American Journal of Hematology
·
28
PDF
Show more works
View as search
Works count:
77
Citation count:
2,308
H-index:
26
I10-index:
41
Year
Topic
Type